Supply breakdown
Shares as of Jul 31, 2026| Category | Shares | % | Value | Status |
|---|---|---|---|---|
| Circulating | 214.34M | 100.0% | $40.14B | Estimated |
| Free float | - | - | - | Unavailable |
| Insider-held, unrestricted | - | - | - | Unavailable |
| Locked team funds | 0 | 0.0% | $0 | Unavailable |
| Other restricted | 0 | 0.0% | $0 | Unavailable |
| Total outstanding | 214.34M | 100.0% | $40.14B | Verified |
| Ownership views (overlap the categories above, never added) | ||||
| Institutional holdings (13F) | 213.87M | 99.8% | $40.05B | Estimated |
| Insider-held, all (Forms 3, 4, 5) | - | - | - | Unavailable |
Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: circulating + locked team + other restricted = total outstanding reconciles.
Valuation
- Traditional$40.14B
- Fully diluted$40.14B
- Circulating$40.14B
- Free float-
- Locked team value$0
- Other restricted value$0
Locked and restricted shares
Not reviewed yet.
Institutional holders
| Holder | Shares | % of total |
|---|---|---|
| BlackRock, Inc. | 13.70M | 6.39% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.55M | 6.32% |
| FMR LLC | 12.20M | 5.69% |
| BAKER BROS. ADVISORS LP | 11.44M | 5.34% |
| Jupiter Topco LLC | 10.74M | 5.01% |
| Darwin Global Management, Ltd. | 10.63M | 4.96% |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.09M | 4.24% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.29M | 3.87% |
| Nextech Invest Ltd. | 7.60M | 3.55% |
| Paradigm Biocapital Advisors LP | 6.36M | 2.97% |
Insiders
Forms 3, 4 and 5Form 4 aggregation pending
Share classes
| Class | Listing | Shares outstanding | As of |
|---|---|---|---|
| Common stock | RVMD on Nasdaq | 214,336,418 | Jul 31, 2026 |
Notes and sources
- Revolution Medicines, Inc. 10-Q for period ended 2026-06-30, Cover page (0001193125-26-335104)
- SEC public float (non-affiliates): $6.70B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.